Previous Close | 132.00 |
Open | 130.44 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's Range | 132.00 - 132.00 |
52 Week Range | 106.79 - 170.55 |
Volume | 450 |
Avg. Volume | 170 |
Market Cap | 15.735B |
Beta (5Y Monthly) | -0.14 |
PE Ratio (TTM) | 32.16 |
EPS (TTM) | 4.11 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | Jun 04, 2019 |
1y Target Est | N/A |
BIOMERIEUX (BMXMF) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks Industry Outlook Highlights: Apollo Medical, bioMerieux, CareDx and Harrow Health
4 Top Medical Services Stocks to Beat COVID-19 Resurgence Crisis